HeungKong Group Limited Overview
- Investor Type
- Venture Capital
- Investments
- 2
- Portfolio
- 1
- Exits
- 1
HeungKong Group Limited General Information
Contact Information
Primary Investor Type
Venture Capital
Primary Office
- China
HeungKong Group Limited Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| DotBio | 12-Apr-2019 | Seed Round | Drug Discovery | Startup | ||
| 00000000 | 14-Jan-2015 | 0000 00000 | 000 | Application Software | Out of Business |
HeungKong Group Limited Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 00000000 | 01-Oct-2017 | 000 00 00000000 |
HeungKong Group Limited Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialHeungKong Group Limited Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Mei Chak | President | China |
HeungKong Group Limited Co-Investors (1)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Futec Biomedical Investments | 0 |
|
|